过程分析技术
工艺工程
设计质量
医药制造业
造粒
计算机科学
稳健性(进化)
活性成分
生化工程
过程开发
纳米技术
材料科学
新产品开发
在制品
工程类
化学
业务
营销
复合材料
基因
生物
生物信息学
生物化学
运营管理
作者
Madhukiran R. Dhondale,Amritha G. Nambiar,Maan Singh,Abhishek R. Mali,Ashish Kumar Agrawal,Nalini R. Shastri,Pradeep Kumar,Dinesh Kumar
标识
DOI:10.1016/j.xphs.2023.02.005
摘要
Active Pharmaceutical Ingredients (APIs) do not always exhibit processable physical properties, which makes their processing in an industrial setup very demanding. These issues often lead to poor robustness and higher cost of the drug product. The issue can be mitigated by co-processing the APIs using suitable solvent media-based techniques to streamline pharmaceutical manufacturing operations. Some of the co-processing methods are the amalgamation of API purification and granulation steps. These techniques also exhibit adequate robustness for successful adoption by the pharmaceutical industry to manufacture high quality drug products. Spherical crystallization and co-precipitation are solvent media-based co-processing approaches that enhances the micromeritic and dissolution characteristics of problematic APIs. These methods not only improve API characteristics but also enable direct compression into tablets. These methods are economical and time-saving as they have the potential for effectively circumventing the granulation step, which can be a major source of variability in the product. This review highlights the recent advancements pertaining to these techniques to aid researchers in adopting the right co-processing method. Similarly, the possibility of scaling up the production of co-processed APIs by these techniques is discussed. The continuous manufacturability by co-processing is outlined with a short note on Process Analytical Technology (PAT) applicability in monitoring and improving the process.
科研通智能强力驱动
Strongly Powered by AbleSci AI